US2196199A - Preventing coagulation of blood - Google Patents

Preventing coagulation of blood Download PDF

Info

Publication number
US2196199A
US2196199A US11796136A US2196199A US 2196199 A US2196199 A US 2196199A US 11796136 A US11796136 A US 11796136A US 2196199 A US2196199 A US 2196199A
Authority
US
Grant status
Grant
Patent type
Prior art keywords
blood
coagulation
metals
neodymium
plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
Inventor
Dyckerhoff Hanns
Original Assignee
Dyckerhoff Hanns
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3672Means preventing coagulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00Surgery
    • Y10S128/22Blood coagulation

Description

April 9, 1940. H. DYCKERHOFF 2,196,199

PREVENTING COAGULATION OF BLOOD Filed Dec. 28, 19ss Patented Apr. 9, 1940 2,196,199 PREVENTING COAGULATION OF BLOOD I V Hanns Dyckerhofl', Munich Germany ApplicationDecember as, 1936, Serial No. 117,961

In Germany December 21, 1935 4 m (01. 167-78) This invention relates to the. treatment of blood for the purpose of preventingits coagulation. I

Hitherto magnesium ions 'or"oxalate. ions have been used'for producing non-coagulating blood orplasma. Of both ions, however, rather high concentrations were-requiredfor preventing coagulation; there was the further drawback of rather powerful toxic effects, whichdefinitely o barred the transfer of non-coagulatingblood,

prepared in this way, fromjthe bodyof; the. dispensing'person into the .body of the diseasedv "person in the case of bloodtransfusions. The minimum concentration of ions required for preparing non-coagulating blood by means of magnesium ions is calculated attwo tenths millimole for 4 cm plasma or millimole if oxalate ions are used.

It is an objectof my invention to make it pos o sible to carry out blood v transfusions without danger of coagulation of the blood and while,

avoiding'the addition to the blood of substances having a toxic effect. v

Another object of my invention is to prevent 26 the coagulation of blood by means of practically insoluble or difii cultly soluble substances.

I have foundthat the metals of the rare earths and their diflicultly soluble and insoluble combinations are especially adapted to prevent or I 30 check coagulation of the blood. The coagulation of the blood can be prevented or checked after it has been extracted from the body. This method of applying the, process is of practical importance, e. g., for carrying out blood'transfu- I have found that the effect of preventingqblood coagulation may be obtained already by means of the metals of the rare earths themselves or by means of their diflicultly soluble compositions; 40 e. g., by this means that containers or conduits and similar conveyances. contacting with the blood are used, which consist of, or are covered with, metals or diflicultly soluble compositions of these metals; d

45 This action of the metals of the rare earths or their diflicultly soluble compositionsis of practical importance, before all,- when carrying out transfusions of blood, but also during other operations, where instruments and similar objects made from metal contact with the blood. By

using syringes with injection pipes-if necessary also cylinder and piston-made from, or covered with, metal of the rare earths or of theirinsoluble compositions such as oxides by trans- 55 ferring the-blood through pipes or collecting it in blood, and at 0.65 tenth beakers or similar containers made from, or covered with, thematerials aforesaid, the coagulation of the blood is prevented'owing to the -described action of the earth metal ions. As-is known to the art in view of other metals and the like, the instruments or accessory implements may be covered, e. g., with neodymium or the respective oxides, only at the surfaces contacting with the blood. v i Non-coagulating plasma is prepared in this "10 way, that the blood is extracted and is first made non-coagulating according to the aforesaid meth- 0d and'is separated from the not dissolved component parts by'means of acentrifugegor by sedimentation or similar methods. method is to make the blood run directly into the centrifuge beaker made from, or covered with, the metals of the rare earths, and to subject the blood'at once to'the centrifuging process.

In the drawing, accompanying this specification '20 and forming part thereof, two receptacles are illustrated byway of example, which consist, ac-

cording-to my invention, of a rare earth metal at the points contacting with the blood.

Fig. 1 is a view of an injection syringe;

Fig. 2 illustrates, by way of example, a centrifuge beaker adapted to the preparation of noncoagulating plasma or to collect the blood for the purpose of blood transfusion.

The receptacles are of the usual shape, dif- Q fering, however, from those hitherto used in this respect'that the injection pipe of the syringe. consists'of neodymium, and that the cylinder as well as the piston are .covered with neodymium. The inside of the centrifuge beaker is also covered with metallic neodymium. In a similar way also the small pipes used,-e. g., during blood transfusions are covered inside with a film ofmetallic neodymium. In this place of metallic neodymium also neodymium oxide may be used, 40

which maybe burnt onto a layer of another material.

' It will be understood that, the foregoing description is in illustration and not in limitation.

tvarious' alternative procedures may be adopted within the scope of the appended claims in which it is my intention to claim broadly all novelty inherent in the invention.

I claim:

1. The process of preventing the coagulation of blood or plasma in a container or the like comprising coating the inside surface of the container or the like 'with a substance selected from the group consisting of the rare earth metals and their diflicultly soluble and insoluble compounds.

A preferred ll The P1 Pr e t ng the coazulation of blood or plasma in a container or the like or blood or plasma in a container or the like comprising providing the container or the like comprising coating the inside surface of the eonwith an inside surface of a substance selected tainer or the like with metallic neodymium, from the group consisting oi! rare earth metals 3. The process of preventing the coagulation of and their difllcultly soluble and insoluble com- I blood or plasma in a container or the like compounds, and maintaining the blood or plasma in prising coating the inside surface of the concontact with the said inside suriace. tainer or the like with neodymium oxide.

4. The process of preventing the coagulation HANNS DYCKERHOFF.

US2196199A 1935-12-21 1936-12-28 Preventing coagulation of blood Expired - Lifetime US2196199A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE2196199X 1935-12-21

Publications (1)

Publication Number Publication Date
US2196199A true US2196199A (en) 1940-04-09

Family

ID=7989576

Family Applications (1)

Application Number Title Priority Date Filing Date
US2196199A Expired - Lifetime US2196199A (en) 1935-12-21 1936-12-28 Preventing coagulation of blood

Country Status (1)

Country Link
US (1) US2196199A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2855933A (en) * 1952-04-04 1958-10-14 American Hospital Supply Corp Fluid receptacle
US2960498A (en) * 1956-04-02 1960-11-15 Burke Oliver W Jun Partial glycerol esters of pectic substances and preparation thereof
US4680177A (en) * 1982-04-28 1987-07-14 Trustees of the Garfield Weston Trust for Research into Heart Surgery Processes for the production of blood products
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
US20070043376A1 (en) * 2003-02-21 2007-02-22 Osteobiologics, Inc. Bone and cartilage implant delivery device

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2855933A (en) * 1952-04-04 1958-10-14 American Hospital Supply Corp Fluid receptacle
US2960498A (en) * 1956-04-02 1960-11-15 Burke Oliver W Jun Partial glycerol esters of pectic substances and preparation thereof
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
US4680177A (en) * 1982-04-28 1987-07-14 Trustees of the Garfield Weston Trust for Research into Heart Surgery Processes for the production of blood products
US20070043376A1 (en) * 2003-02-21 2007-02-22 Osteobiologics, Inc. Bone and cartilage implant delivery device

Similar Documents

Publication Publication Date Title
Bowen Adhesive bonding of various materials to hard tooth tissues. III. Bonding to dentin improved by pretreatment and the use of surface-active comonomer
Kirby et al. Isolation of deoxyribonucleic acid from mammalian tissues
Suter et al. Passage of lipid across vascular endothelium in newborn rats: an electron microscopic study
Adams A histochemical method for the simultaneous demonstration of normal and degenerating myelin
Hunt et al. Effect of gastrin II on gastric emptying and secretion during a test meal
Tilney et al. The polymerization of actin: its role in the generation of the acrosomal process of certain echinoderm sperm
Schmued A rapid, sensitive histochemical stain for myelin in frozen brain sections.
Johnston et al. Comparative Effectiveness of Fourteen Solutions for Extracting Arsenic from Four Western New York Soils 1
Jones et al. Sequence of events in experimental metastases of Walker 256 tumor: light, immunofluorescent, and electron microscopic observations
Hong et al. Chronic treatment with haloperidol accelerates the biosynthesis of enkephalins in rat striatum.
Page et al. The cause of the blood coagulation defect following abruptio placentae
Day et al. BIG RENIN: A POSSIBLE PROHORMONE IN KIDNEY AND PLASMA OF A PATIENT WITH WILMS'TUMOR
Shetty et al. Effective Reversal of Warfarin-lnduced Excessive Anticoagulation with Low Dose Mtamin K1
US4340586A (en) Pharmaceutical preparation for treating disorders of the skin
Kay The mechanism by which experimental nephritis is produced in rabbits injected with nephrotoxic duck serum
US5512286A (en) Extract from leaves of ginkgo biloba for intravenous injection or infusion
Seifter et al. Lipid mobilizer (LM) from posterior pituitary of hogs.
Korngold et al. The localization of antilymphosarcoma antibodies in the Murphy lymphosarcoma of the rat
Ching Correlative surges of LHRH, LH and FSH in pituitary stalk plasma and systemic plasma of rat during proestrus
Spector et al. The effect of vascular permeability factors on the emigration of leucocytes
Levy et al. Effect of complex formation on drug absorption V. Studies on the mechanism of the secobarbital absorption‐enhancing effect of polysorbate 80 in goldfish
Wang et al. Treatment of acute lymphocytic leukemia by high-dose intravenous methotrexate
Swift et al. Gel chromatography of humic acid
US3410839A (en) Immunochromatographic partition of soluble antigens
Campbell et al. Plasma albumin as an acceptor of free fatty acids